Luveltamab tazevibulin,Pegfilgrastim
Sutro Biopharma,Amgen
['pivot,io,i', 'ovarian', '$stro', 'sutro']
$stro sutro biopharma announces oral presentation at asco 2023 featuring data for luveltamab tazevibulin from the phase 1 dose-expansion study in ovarian cancer and the initiation of the phase 2/3 pivotal s 
Full-time trader. My tweets are ideas & opinions. Don't trade based on them. Read Reminiscences of a Stock Operator.